AndrewJosephAhmannMD

PubMed

• 1 citations
  Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial.
  W Timothy Garvey, Robert M Cohen, Nicole M Butera, Erin J Kazemi, Naji Younes, Samuel P Rosin, Colleen E Suratt, Andrew Ahmann, Priscilla A Hollander, Jonathan Krakoff...> ;Diabetes Care. 2024 Apr 1
• Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) bas...
  Barbara I Gulanski, Nicole M Butera, Heidi Krause-Steinrauf, Judith H Lichtman, Tasma Harindhanavudhi, Jennifer B Green, Colleen E Suratt, Hiba AbouAssi, Cyrus Desouza...> ;BMJ Open Diabetes Research & Care. 2023 Apr 1
• 22 citations
  Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes.
  Kellee M Miller, Lauren G Kanapka, Michael R Rickels, Andrew J Ahmann, Grazia Aleppo, Lynn Ang, Anuj Bhargava, Bruce W Bode, Anders Carlson, Naomi S Chaytor, Gail Gann...> ;Diabetes Technology & Therapeutics. 2022 Jun 1
• 2 citations
  The cross-sectional association of cognition with diabetic peripheral and autonomic neuropathy-The GRADE study.
  Joshua I. Barzilay, Alokananda Ghosh, Rodica Pop Busui, Andrew J. Ahmann, Ashok Balasubramanyam, Mary Ann Banerji, Robert M. Cohen, Jennifer B. Green, Faramarz Ismail-...> ;Journal of Diabetes and Its Complications. 2021 Sep 15
• 23 citations
  Type 2 Diabetes and the Use of Real-Time Continuous Glucose Monitoring
  Melanie A. Jackson, Andrew J. Ahmann, Viral N. Shah> ;Diabetes Technology & Therapeutics. 2021 Mar 2
• 156 citations
  Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
  Richard E. Pratley, Lauren Kanapka, Michael R. Rickels, Andrew J. Ahmann, Grazia Aleppo, Roy W. Beck, Anuj Bhargava, Bruce W. Bode, Anders E. Carlson, Naomi Chaytor, D...> ;JAMA. 2020 Jun 16
• 7 citations
  How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future.
  Jessica R. Castle, Lolis Rocha, Andrew J. Ahmann> ;Journal of Diabetes Science and Technology. 2020 May 22
• 19 citations
  Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM Study:
  Anders L. Carlson, Lauren Kanapka, Kellee M. Miller, Andrew J. Ahmann, Naomi Chaytor, Steven Fox, Lisa Kiblinger, Davida F. Kruger, Carol J. Levy, Anne L. Peters, Mich...> ;Journal of Diabetes Science and Technology. 2021 May 1
• 96 citations
  Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 ...
  Vanita R. Aroda, Andrew J. Ahmann, Bertrand Cariou, F. Chow, Melanie J. Davies, Esteban Jódar, Raj Mehta, Vincent Woo, Ildiko Lingvay> ;Diabetes & Metabolism. 2019 Jan 4
• 51 citations
  Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults.
  Yogish C. Kudva, Andrew J. Ahmann, Richard M. Bergenstal, James R. Gavin, Davida F. Kruger, L. Kurt Midyett, Eden Miller, Dennis R. Harris> ;Journal of the Endocrine Society. 2018 Nov 14
• 16 citations
  Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines.
  Anne L. Peters, Andrew J. Ahmann, Irl B. Hirsch, Jennifer K. Raymond> ;Journal of the Endocrine Society. 2018 Oct 5
• 53 citations
  T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes
  Lawrence Fisher, Danielle Hessler, William H. Polonsky, Umesh Masharani, Susan Guzman, Vicky Bowyer, Lisa A. Strycker, Andrew J. Ahmann, Marina Basina, Ian Blumer, Cha...> ;Diabetes Care. 2018 Sep 1
• 289 citations
  Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial*
  Andrew J. Ahmann, Matthew Capehorn, Guillaume Charpentier, Francesco Dotta, Elena Henkel, Ildiko Lingvay, Anders G. Holst, Miriam Annett, Vanita R. Aroda> ;Diabetes Care. 2017 Dec 15
• 61 citations
  A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes.
  Grazia Aleppo, Lori M. Laffel, Andrew J. Ahmann, Irl B. Hirsch, Davida F. Kruger, Anne L. Peters, Ruth S. Weinstock, Dennis R. Harris> ;Journal of the Endocrine Society. 2017 Nov 20
• 284 citations
  Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
  Roy W. Beck, Tonya D Riddlesworth, Katrina J. Ruedy, Andrew J Ahmann, Stacie Haller, Davida F. Kruger, Janet B. McGill, William H. Polonsky, David C. Price, Stephen Ar...> ;Annals of Internal Medicine. 2017 Sep 19
• 23 citations
  Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies
  Janet B. McGill, Andrew J. Ahmann> ;Diabetes Technology & Therapeutics. 2017 Jun 1
• 181 citations
  REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes
  , , , , , , , , , , , , , , , , , > ;Diabetes Care. 2017 Apr 1
• 83 citations
  Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Ev...
  Richard M. Bergenstal, Timothy S. Bailey, David Rodbard, Monika Ziemen, Hailing Guo, Isabel Muehlen-Bartmer, Andrew J. Ahmann> ;Diabetes Care. 2017 Apr 1
• 687 citations
  Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
  Roy W. Beck, Tonya D Riddlesworth, Katrina J. Ruedy, Andrew J. Ahmann, Richard M. Bergenstal, Stacie Haller, Craig Kollman, Davida F. Kruger, Janet B. McGill, William ...> ;JAMA. 2017 Jan 24
• 10 citations
  Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninfer...
  Michael R Rickels, Katrina J Ruedy, Nicole C Foster, Claude A Piché, Hélène Dulude, Jennifer L Sherr, William V Tamborlane, Kathleen E Bethin, Linda A DiMeglio, R Paul...> ;Diabetes Care. 2016 Oct 1
• 130 citations
  Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline
  Anne L. Peters, Andrew J. Ahmann, Tadej Battelino, Alison B. Evert, Irl B. Hirsch, M. Hassan Murad, William E. Winter, Howard Wolpert> ;The Journal of Clinical Endocrinology and Metabolism. 2016 Sep 2
• 20 citations
  Reliability of Trained Dogs to Alert to Hypoglycemia in Patients With Type 1 Diabetes.
  Evan Los, Katrina Ramsey, Ines Guttmann-Bauman, Andrew J. Ahmann> ;Journal of Diabetes Science and Technology. 2017 May 1
• 86 citations
  Glucose variability in a 26-week randomized comparison of mealtime treatment with rapid-acting insulin versus glp-1 agonist in participants with type 2 diabetes at hig...
  Jeffrey L. Probstfield, Irl B. Hirsch, Barry R. Davis, Andrew J. Ahmann, Richard M. Bergenstal, Matthew P. Gilbert, Connie Kingry, Dorrine Khakpour, Dejian Lai, Sarah ...> ;Diabetes Care. 2016 Jun 1
• 112 citations
  Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes
  Ruth S. Weinstock, Stephanie N. DuBose, Richard M. Bergenstal, Naomi Chaytor, Christina Peterson, Beth A. Olson, Medha Munshi, Alysa J.S. Perrin, Kellee M. Miller, Roy...> ;Diabetes Care. 2016 Apr 1
• 78 citations
  Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: A randomized crossover noninferiority study
  Michael R. Rickels, Katrina J. Ruedy, Nicole C. Foster, Claude A. Piché, Hélène Dulude, Jennifer L. Sherr, William V. Tamborlane, Kathleen E. Bethin, Linda A. DiMeglio...> ;Diabetes Care. 2015 Dec 16
• Join now to see all

Journal Articles

• T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults with Type 1 Diabetes  
  Sarah Kim, Umesh Masharani, Andrew Ahmann, William H Polonsky, Karen Weihs, Martha Shumway, Diabetes Care
• Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo-...  
  Ahmann A, Rodbard HW, Rosenstock J, Lahtela JT, de Loredo L, Tornoe K, Boopalan A, Nauck MA, Diab Obes Metab, 1/1/2015
• T1D Exchange Severe Hypoglycemia in Older Adults with Type 1 Diabetes Study Groups  
  Weinstock RS, DuBose SN, Bergenstal RM, Chaytor NS, Peterson C, Olson BA, Munshi MN, Perrin AJ, Miller KM, Beck RW, Lilgenquist DR, Aleppo G, Buse JB, Kruger D, Bharga..., Diabetes Care, 1/1/2015
• Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study  
  Weiss R, Garg SK, Bode BW, Bailey TS, Ahmann AJ, Schultz KA, Welsh JB, Shin JJ., Diabetes Technol Ther, 1/1/2015
• Accuracy and Acceptability of the 6-Day Enlite Continuous Subcutaeneous Glucose Sensor  
  Bailey T, Ahmann A, Brazg R, Christiansen M, Garg S, Watkins E, Welsh J, Lee S., Diabetes Technol Ther, 1/1/2014
• Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen Versus Vial-and-Syringe Insulin Delivery in Patients with Type 2 Diabetes  
  Ahmann A, Szeinbach SL, Gill J, Traylor L, Garg SK, Diabetes Technol Ther, 1/1/2014
• Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP)  
  Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson B..., Diabetes Technol Ther., 1/1/2013
• Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs beta-cell function  
  Long SA, Rieck M, Sanda S, Bollyky JB, Samuels PL, Goland R, Ahmann A, Rabinovitch A, Aggarwal S, Phippard D, Turka LA, Ehlers MR, Bianchine PJ, Boyle KD, Adah SA, Blu..., Diabetes, 1/1/2012
• Rapamycin/ IL-2 combination therapy in type 1 diabetes augments Treg yet transiently impairs beta cell function  
  Long SA, Rieck M, Sanda S, BollyKy JB, Samuels RL, Goland R, Ahmann A, Rabinovitch A et al., Diabetes, 1/1/2012
• Application of comparative effectiveness research in evaluation of treatments for type 2 diabetes mellitus  
  Ahmann A., Am J Manag Care., 1/1/2011
• Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience  
  Buse JB, Dailey G, Ahmann AA, Bergenstal RM, Green JB, Peoples T, Tanenberg RJ, Yang Q., Diabetes Technol Ther., 1/1/2011
• Application of Compartive Effectiveness Research in Evaluation of Treaments for T2DM  
  Ahmann A, Am J Managed Care, 1/1/2011
• Baseline Predicors of A1c Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Theray: The STAR 3 Eperience  
  Buse JB, Dailey G, Ahmann A, Bergenstal RM, Green JB, Peoples MA, Tanenberg RJ, Yang Q., Diabetes Tech Ther, 1/1/2011
• Safety, pharmacokinetic profile, and metabolic effects of 14 days of treatment with DIO-902: results of a randomized, placebo-controlled randomized trial in patients w...  
  Schwartz SL, Rendell M, Ahmann AJ, Thomas A, Arauz-Pacheco CJ, Welles BR, Clinical Therapeutics., 1/1/2008
• Effects of a low fat diet compared to a high monounsaturated fat diet upon body weight, plasma lipids, lipoproteins, and glycemic control in type 2 diabetes  
  Gerhard GT, Ahmann A, Meeuws K, McMurry M, Duell PD, Conner WE, Am J. Clin Nutrition, 1/1/2004
• What to Do When Two Oral Agents Fail to Control Type 2 Diabetes – A Matter of Opinion or A Matter of Fact  
  Ahmann, AJ, Riddle MC, Am J Med, 1/1/2004
• Reduction of hospital costs and length of stay by good control of blood glucose levels  
  Ahmann, AJ., Endocrine Practice, 1/1/2004
• Technical Review: Management of Diabetes and Hyperglycemia in Hospitals  
  Clement S, Hirsch I, Ahmann AJ, Magee M, Braithwaite S, Smith P., Schafern, R., Hirsch, I., Diabetes Care., 1/1/2004
• Analysis: Lessons on developing a better basal insulin  
  Ahmann A, Diabetes Technology and Therapeutics., 1/1/2004
• Managing the major complications of diabetes  
  Ahmann AJ, Comi R, Patient Care, 1/1/2004
• Current oral agents for type 2 diabetes  
  Ahmann AJ, Riddle MC, Postgraduate Medicine, 1/1/2002
• Diagnostic and Therapeutic Considerations in Adults with Diabetes Mellitus  
  Peters A, Ahmann AJ, and Rayburn K., J Clinical Outcomes Medicine, 1/1/1998
• A Comprehensive Approach to the Hospitalized Patient with Diabetes  
  The Endocrinologist., 1/1/1998
• Transcontinental Shipping of Pancreatic Islets for Auto-transplantation After Total Pancreatectomy  
  Rabkin JM, Leone JP, Sutherland DER, Ahmann AJ, Reed M, Paplois BE, Wahoff DC, Pancreas, 1/1/1997
• Endocrine-Metabolic Effects of Asthma Treatment: The Impact of Glucocorticoid Therapy in the Elderly  
  Ahmann AJ, Immunol Allergy Clin N.Am, 1/1/1997
• Join now to see all

Books/Book Chapters

• Insulin Therapy 
  Chapter: Insulin Therapy in Type 2 Diabetes Mellitus 
  Ahmann AJ, Riddle MCEditors: Leahy JL & Cafalu WT..Marcel Dekker, Inc.2002
• Conn’s Current Therapy 
  Chapter: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome 
  Ahmann AJ, Riddle MC.Editors: Rakel RE, Bope ET.W.B. Saunders Co.2001
• The Medical Management of Diabetes Mellitus. 
  Chapter: Oral Pharmacologic Agents in Type 2 Diabetes 
  Ahmann AJ, Riddle MC.Editors: Cefalu WT, Clark NG & Leahy JL..Marcel Dekker.2000
• Principles and Practices of Endocrinology and Metabolism 
  Chapter: The Thyroid Nodule. 
  Ahmann A, Wartofsky LEditors: Becker KL.J.B. Lippincott Co., Philadelphia1995
• Join now to see all

Abstracts/Posters

• Hypoglycemia Rates with Titration of Prandial or Basal Bolus Insulin Therapy in Patients with Type 2 Diabetes
  Ahmann A, Jiang H, Martin SA., Diabetes, 1/1/2008
• A Comparison of Prandial Premixed (ILPS/Lispro) vs Basal Bolus (glargine/Lispro) Insulin Therapy in Obese Patinets with Type 2 Diabetes.
  Ahmann A, Jiang H, Martin S., Diabetes, 1/1/2008
• Intenisive Insulin Therapy in Type 2 Diabetes (T2D) Patients Previously Treated with Glargine Plus Oral Agnets: Prandial NPL/Lispor Mixtures vs Glargine/ lispro Basal/...
  Rosentstock, J, Ahmann AJ, Colon G, Scism-Bacon JL, Jiang HH, Martin S., Diabetes, 1/1/2007
• Metabolic Effects of 14-Day Treatment with DIO-902: Results of a Randomized Placebo-Controlled Trial in Patients with Type 2 Diabetes.
  Schwartz S, Rendell M, Ahmann A, Thomas A, Arauz-Pacheco C, Welles B., Diabetes, 1/1/2007
• Human Factors Assessment for Measuring Glucose Non-Invasively.
  Jovanovic L, Ahmann A, Edelman S, fischer J, Garg S, Monfre S, Ruchti T., Diabetes, 1/1/2007
• Improved HbA1c levels through the use of an electronic logbook incorporating data displays: A multicenter, randomized, controlled trial.
  Hsu W, Laffel L, McGill BJ, Meneghini L, Kaiserman K, Donner T, Counts D, Ahmann A, Einhorn D., Diabetes, 1/1/2005
• Diabetes Management of Medicare patients Enrolled in Managed Care: A Patient Centered Analysis.
  Medak, R, Lucas J, Ahmann, AJ., Diabetes, 1/1/2003
• Isolation of the Immune Response in Hashimoto’s Disease to Intrathyroidal Lymphocytes and the Production of Human Monoclinal Antibodies From there Lymphocytes.
  Baker JR, Saunders NB, Tseng YC, Wartofsky L, Ahmann AJ, Burman KD., 61st Meeting of the American Thyroid Association, 1/1/1986
• Development of an Antigen-Responsive Intra Thyroidal T-Cell Population: Evidence that Thymocyte Antigens and OKT 3 T-Cell Receptor Mediate Cellular proliferation.
  Ahmann AJ, Baker JR, Wartofsky L, Burman KD., 61st Meeting of the American Thyroid Association, 1/1/1986
• Serum Immunoglobulins in Patients with Graves Ophthalmopathy Directed against Unique Determinants of Porcine Eye Muscle.
  Ahmann AJ, Baker JR, Weetman AP, Wartofsky L, Nutman T, Burman KD., Annual Meeting American Federation for Clinical Research, Washington, DC, 1/1/1986
• Evidence for Antibodies for Porcine Eye Muscle in Endocrine Ophthalmopathy
  Ahmann AJ, Baker JR, Wartofsky L, Weetman AP, Burman KD., Regional ACP meeting, San Francisco, CA, 1/1/1985
• Glucose Levels Assessed by Continuous Glucose Monitoring (CGM) across the Pediatric Age Range in Youth with Type 1 Diabetes (T1D).
  Laffel LM, Bailey TS, Ahmann AJ, Tsalikian E, Chase P, ADA 75th Scientific Sessions, Boston, MA, 1/5./2015
• 2369-PO - Bolus Insulin Dosing and Nocturnal Hypoglycemia in the ASPIRE In-Home Study View session detail.
  Weiss R, Schwartz FL, Weinstock RS, Bode BW, Bailey T, Ahmann AJ, Kaufman F, ADA 74th Scientific Sessions, San Francisco, CA, 1/13/2014
• 331-OR - Efficacy and Safety of Liraglutide vs. Placebo When Added to Basal Insulin Analogs in Patients with Type 2 Diabetes (LIRA-ADD2BASAL)
  Ahmann AJ, Rodbard HW, Rosenstock J, Lahtela J, De Loredo L, Tornoe K, Boopalan A, Nauch MA., ADA 74th Scientific Sessions, San Francisco, CA, 1/13/2014
• 231-OR - Hypoglycemia Reduction and Changes in A1C in the ASPIRE In-Home
  Bailey TS, Weiss R, Bode BW, Garg S, Ahmann AJ, Welsh JB, Lee SW, Aspire In-Home Study Group, ADA 74th Scientific Sessions, San Francisco, CA, 1/13/2014
• 940-P - Time Spent (%) in Hypoglycemia Following Automatic Threshold Suspend Activation in the ASPIRE In-Home Study.
  Weiss R, Bailey TS, Schwartz FL, Garg S, Ahmann AJ, Thrasher J, Huang S, Lee SW, Aspire In-Home Study Group, ADA 74th Scientific Sessions, San Francisco, CA, 1/13/2014
• 1616P Presidual C-Peptide in pateints 3-81 years from diagnosis of T1D: A T1D Exchange Study.
  Davis A, Haller MJ, Miller K, Dubose S, Carpenter C, Dimeglio L, Liljenquist DR, Ahmann A, Marcovina SM, Greenbaum C, Beck RW., ADA 73rd Annual Scientific Sessions, Chicago, IL, 1/11/2013
• Reduction in Hypoglycemia and No Increase in A1C with Threshold-Based Sensor-Augmented Pump (SAP) Insulin Suspension: ASPIRE In-Home
  Bergenstal RM, Klonoff R, Bode BW, Garg SL, Ahmann A, Slover R, Meredith M, Kaufman FR, Aspire In-Home Study Group, ADA 73rd Annual Scientific Sessions, Chicago, IL, 1/21/2013
• Factors Associated with Hemoglobin A1c levels Among Adult Participants in the T1D Exchange Clinic Registry.
  Ahmann AJ, Cheng P, Beck RW, Bergenstal RM, Bode BW, Garg S, Miller KM, Olson BA, American Diabetes Association 72nd Scientific Sessions, Philadelphia, PA, 1/8./2012
• Patient Preference and Clinical Outcomes Associated with Initiation of Insulin Glargine Therapy for Type 2 Diabetes Using Disposable Pen versus Vial.
  Ahmann A, Szeinbach SL, Gill J, Traylor L, Garg S., American Diabetes Association 72nd Scientific Sessions, Philadelphia, PA, 1/8./2012
• Sensor-Augmented Pump Therapy for A1c Reduction (STAR 3) Study: Results from the 6-Month Continuation Phase.
  Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis, SN, Joyce C, Peoples, T, Perkins BA, Welsh JB, Willi SM, Wood MA, American Diabetes Association 71st Annual Scientific Sessions, San Diego, CA, 1/24/2011
• Efficacy and Patient Satisfaction of Human U-500 Insulin Administration by Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion Regimen in Obese, ...
  Yuen KCJ, Lester LR, Hohn SB, Ahmann AJ, 92nd Annual Endocrine Society Meeting, San Diego, CA, 1/19/2010
• Metformin+Exenatide+Basal Insulin vs Metformin+Placebo+Basal Insulin: Reaching A1c<6.5% Without Weight-Gain or Serious Hypoglycemia.
  Riddle M, Andrew A, Basu A, Vanita A, Ratner R, American Diabetes Association 70th Scientific Sessions, Orlando, FL, 1/25/2010
• Low dose Metformin Added to Sulfonylures: Comparison of Two Regimens.
  Riddle MC, McDaniel PA, Mitchell ML, Ahmann AJ, Karl DM., International Society of Endocrinology, 1/12/1996
• Species-Specific and Age-Related Heterogeneity in 125-I ANP Binding to Thyroid Tissue.
  Ahmann AJ, Barnes S, Galloway R., 71st Annual Endocrine Society Meeting, Seattle, WA, 1/21/1989
• Join now to see all

Lectures

• The Butterfly Effect: Resurrection of the Beta Cell in Type 2 Diabetes. 
  San Francisco, CA - 1/1/2007
• Approaches to Reducing Hypoglycemia and Hypoglycemic Unawareness 
  Chennai, India - 1/21/2015
• Update in Basal Insulins: Your Questions Answered 
  Miami, FL - 1/11/2015
• Review of Newer Medications For Type 2 Diabetes: Seeing Clearly Through the Fog 
  Portland, OR - 1/21/2015
• Management of NODAT with Oral Therapies and Insulin 
  Boston, MA - 1/6./2015
• Back to Basals: Optimizing Basal Insulin Therapy 
  San Diego, CA - 1/5./2015
• Evolving Insulin Therapy: Optimzing Care Through Proper Selection and Use. 
  Multiple locations - 1/9./2015
• Update on Oral Agents for T2DM 
  Seattle, WA - 1/28/2015
• Insulin Therapy in Patients with Type 2 Diabetes: Current and Emerging Basal Insulins. 
  Multiple locations - 1/15/2014
• Type 2 Diabetes in Pediatrics: Medication Update 
  Vancouver, BC - 1/1./2014
• Inpatient Management of Diabetes: Case Management Forum 
  Houston, TX - 1/24/2012
• Utilizing What We Know to Change The Impact of Diabetes Care Delivery 
  Reno, Nevada - 1/17/2012
• Advances in Technology and Systems for Inpatient Management of Hyperglycemia 
  San Diego, CA - 1/26/2011
• Inpatient Diabetes Care 
  Terre Haute, IN - 1/11/2010
• Endocrine reviews for primary care on Type 1 diabetes, Type 2 diabetes, hyperlipidemia and obesity with the Medical Education Resources CME program 
  Phoenix, AZ - 1/10/2008
• Managing the Complexities of Type 2 Diabetes: A Roadmap for Patient Care. 
  Seattle, WA - 1/26/2008
• Glycemic Control In The Hospital: A Case-Based Team Approach 
  San Francisco, CA - 1/25/2007
• Initiation, Integration, and Implementation of Insulin In the Hospital 
  Seattle, WA - 1/11/2007
• Systematically Improving the Management of Diabetes: A Review of Current Guidelines, recommendations, and Performance Measures 
  Chicago, IL - 1/5./2006
• Catching the Wave 
  St. Joseph’s Hospital/ Marshfiled Clinic, Marschfild, WS - 1/28/2006
• Diabetes and Heart Disease: The Deadly Connection. 
  Alaska Regional Hospital, Anchorage, AK - 1/19/2006
• Pharm Med Updates 
  Pri-Med Institute.’ Los Angeles, CA - 1/11/2006
• Examining Insulin therapy in Type 2 Diabetes 
  University of Colorado School of Medicine, Denver, CO - 1/12/2006
• The Endocannabinoid System: A New Target for the Reduction of Cardiovascular Risk Factors 
  San Diego, CA - 1/2./2006
• Insulin Therapy in the Hospital: Strategies for Improving Patient Outcomes 
  Banner Mesa Medical Center, Mesa, AZ - 1/5./2005
• Join now to see all

Other

• Designing and Implementing Insulin Infusion Protocols and Order Sets. 
  Ahmann A, Maynard G., J Hosp Med. (Online)
  1/1/2008
• Building and Implementing an Insulin Infusion Order Sets and Protocols In Workbook for Improvement: Improving Glycemic Control, Preventing Hypoglycemia, And Optimizing... 
  Ahmann A, Hellman R, Maynard G., Society of Hospital Medicine
  www.hospitalmedicine.org
  1/1/2007
• Guides Audio Poster Tour Moderator for Pharmacologic Treatment Of Diabetes – Novel Therapies. 
  American Diabetes Association Scientific Sessions
  San Diego, CA - 1/26/2011
• Focus On Inpatient Diabetes Management 
  American Association of Clinical Endocrinologists “Clinical Conversations”
  www.aace.com
  1/13/2007
• Improving Outcomes Through Glucose Control in the Hospital 
  VHA Live Televised CME Program
  Dallas, TX - 1/20/2005
• Join now to see all